PULMOGENIX.COM

Home

Physician and Patient Benefit. PulmoGeniX™, Inc. is a technology licensing and joint development relationship forged between Mayo Clinic and Sanovas, Inc. to commercialize significant innovations to treat and cure the most severe cases of asthma. The PulmoGeniX system is a first-in-kind suite of diagnostic and therapeutic tools for Bronchial Smooth Muscle Modification Therapy. Mdash; Larry Gerrans, CEO of Sanovas. FDA REGULATORY DISCLOSURE: PulmoGeniX , Inc. is an emerging technology company. The...

http://www.pulmogenix.com/

OVERVIEW OF pulmogenix.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

7

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR PULMOGENIX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 3.9 out of 5 with 18 reviews

5 star

9

4 star

3

3 star

4

2 star

0

1 star

2

Hey there! Start your review of pulmogenix.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.1 seconds

CONTACTS AT PULMOGENIX.COM

Lawrence Gerrans

28 Gre●●●●●●h Lane

San ●●●●elmo , California, 94960

United States

1.92●●●●3278

1.41●●●●9389

lg●●●●●●@yahoo.com

View this contact

Lawrence Gerrans

28 Gre●●●●●●h Lane

San ●●●●elmo , California, 94960

United States

1.92●●●●3278

1.41●●●●9389

lg●●●●●●@yahoo.com

View this contact

Lawrence Gerrans

28 Gre●●●●●●h Lane

San ●●●●elmo , California, 94960

United States

1.92●●●●3278

1.41●●●●9389

lg●●●●●●@yahoo.com

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2014 January 29
UPDATED: 2014 February 09
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

11

YEARS
5

MONTHS
26

DAYS

NAME SERVERS

1: ns1.sanovas.com
2: ns2.sanovas.com

REGISTRAR

GODADDY.COM, LLC

WHOIS : whois.godaddy.com

REFERRED : http://registrar.godaddy.com

CONTENT

PAGES IN
THIS WEBSITE

7

SSL

EXTERNAL LINKS

0

SITE IP

67.210.104.50

LOAD TIME

1.141 sec

SCORE

6.2

PAGE TITLE

Home | pulmogenix.com Reviews

<META> DESCRIPTION

Physician and Patient Benefit. PulmoGeniX™, Inc. is a technology licensing and joint development relationship forged between Mayo Clinic and Sanovas, Inc. to commercialize significant innovations to treat and cure the most severe cases of asthma. The PulmoGeniX system is a first-in-kind suite of diagnostic and therapeutic tools for Bronchial Smooth Muscle Modification Therapy. Mdash; Larry Gerrans, CEO of Sanovas. FDA REGULATORY DISCLOSURE: PulmoGeniX , Inc. is an emerging technology company. The...

<META> KEYWORDS

1 company news

2 press releases

3 team

4 technology

5 bronchial thermoplasty

6 market

7 asthma

8 business case video

9 investors

10 larry gerrans

CONTENT

Page content here

KEYWORDS ON PAGE

company news,press releases,team,technology,bronchial thermoplasty,market,asthma,business case video,investors,larry gerrans,craig daniels,mdash;

SERVER

Apache/2.2.29 (Unix) mod_ssl/2.2.29 OpenSSL/1.0.1e-fips mod_bwlimited/1.4

POWERED BY

PHP/5.4.39

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Home | pulmogenix.com Reviews

https://pulmogenix.com

Physician and Patient Benefit. PulmoGeniX™, Inc. is a technology licensing and joint development relationship forged between Mayo Clinic and Sanovas, Inc. to commercialize significant innovations to treat and cure the most severe cases of asthma. The PulmoGeniX system is a first-in-kind suite of diagnostic and therapeutic tools for Bronchial Smooth Muscle Modification Therapy. Mdash; Larry Gerrans, CEO of Sanovas. FDA REGULATORY DISCLOSURE: PulmoGeniX , Inc. is an emerging technology company. The...

INTERNAL PAGES

pulmogenix.com

1

Asthma

http://www.pulmogenix.com/index.php/market/asthma

Physician and Patient Benefit. Asthma is an inflammatory disorder of the airways, which causes attacks of wheezing, shortness of breath, chest tightness, and coughing. During an asthma attack, the muscles surrounding the airways become tight and the lining of the air passages swells. Asthma symptoms can be triggered by breathing in allergy-causing substances, such as pollen and dust. Bull; Asthma affects 25.9 million Americans (1 in 15). Bull; Every day in America:. O 30,000 people have an asthma attack.

2

Market

http://www.pulmogenix.com/index.php/market

Physician and Patient Benefit. The unmet clinical need to treat severe asthmatics is immense. The acute, chronic asthma patient population is represented by more than 2 million severe asthma patients in the U.S. and 8 million worldwide. In addition, a 25% overall increase in patient population is projected by 2025.*. Treatment options include: (1) conventional medication; and, (2) bronchial thermoplasty, a new bronchoscopic procedure intended for the treatment of severe persistent asthma in. In the US, t...

3

Team

http://www.pulmogenix.com/index.php/overview/team

Physician and Patient Benefit. PulmoGeniX™ is led by an expert, experienced team that can turn the companys vision into reality. SAMUEL J. ASIRVATHAM, M.D. Vice Chair, Cardiovascular Diseases. Mayo Clinic, Rochester, MN. Professor of Medicine and Vice Chair, Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic. Consultant in Cardiac Electrophysiology, Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic. CRAIG E. DANIELS, M.D. Certified: Ameri...

4

Company News

http://www.pulmogenix.com/index.php/overview/company-news

Physician and Patient Benefit. Sanovas and Mayo Clinic Enter Joint Development Agreement to Create Technologies to Treat Asthma. Collaboration intended to advance techniques in modification of bronchial smooth muscle. According to the World Health Organization, asthma rates have been surging around the globe over the past three decades with 250,000 annual deaths attributed to the disease. It is estimated that the number of people with asthma will increase as much as 25%, to more than 400 million peop...

5

Overview

http://www.pulmogenix.com/index.php/overview

Cystic and Pulmonary Fibrosis. Access, Imaging, Measurement (AIM). The company’s strategy is to expand globally the diagnosis and treatment of obstructions and pathologies in the lungs. To execute this strategy, PulmoGeniX seeks to evolve the current paradigm of intervention by creating smarter, more efficient, less invasive, lower-risk and more cost-effective tools and technologies that can be easily adopted worldwide by all physicians who are focused on the treatment of the airways. Enabling physicians...

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL PAGES IN THIS WEBSITE

7

OTHER SITES

pulmodata.si

Pulmodata

Terapija s kisikom na domu. Sistem za dovajanje tekočega kisika. Prenosne jeklenke s kisikom. Ustekleničen čisti kisik O-PUR. Aparat za vzdrževanje stalnega pritiska v dihalnih poteh (CPAP). Aparat za podporo dihanju s pozitivnim tlakom (BIPAP). Ventilator - aparat za umetno predihavanje pljuč. Električni razpršilec zraka - inhalator. Nastavek z masko za dajanje zdravil. Naprstni (otroški, odrasli). Medicinski pripomoček za izkašljevanje (FLUTTER). Sistemi za provokacijske teste. Trening in masaža pljuč.

pulmodyne.com

Pulmodyne

pulmoflow.com

PulmoFlow, Inc. - About Us

pulmofr.org

La tuberculose pulmonaire

Les symptômes de cette maladie sont une fièvre (38 à 38,5 degrés), une toux qui peut s'accompagner d'hémoptysie (rejet de sang lors de la toux) et qui dure plus de trois semaines, une grande fatigue, un amaigrissement important et rapide (de l'ordre de 5 à 10 kilos en un mois seulement) ainsi que des sueurs nocturnes. La maladie peut toucher tout le monde. Certaines personnes sont néanmoins plus à risque. Il s'agit des personnes en contact avec les malades (professionnels de la santé et proches) ...La ma...

pulmogene.unibas.ch

Pulmonary Gene Research

Active projects (password protected). The Pulmonary Gene Research group was founded in June 2004 by Martin Brutsche, MD, PhD (second left). It consists of Michaël Facompré PhD, an experienced bench-side researcher (second right), Florent Baty PhD, a biostatistician and specialist for multivariate analyses (right), and Meiyin Gao (left), a PhD student in bioinformatics.

pulmogenix.com

Home

Physician and Patient Benefit. PulmoGeniX™, Inc. is a technology licensing and joint development relationship forged between Mayo Clinic and Sanovas, Inc. to commercialize significant innovations to treat and cure the most severe cases of asthma. The PulmoGeniX system is a first-in-kind suite of diagnostic and therapeutic tools for Bronchial Smooth Muscle Modification Therapy. Mdash; Larry Gerrans, CEO of Sanovas. FDA REGULATORY DISCLOSURE: PulmoGeniX , Inc. is an emerging technology company. The...

pulmogenomics.com

pulmogenomics.net

Main Page - Pulmogenomics.net

BiO network is on-line information source for all the areas of biological research, technology, training, and business. Anyone is welcome to contribute to and use the content with maximum freedom. Please visit our sites that are listed in. Some of our sites are. The free encyclopedia of biology. The internet sites directory for biological science, technology, and business. The free Oenomics portal. The Omics home page for everyone. The international portal for biological information for the countries.

pulmogenomics.org

Main Page - Pulmogenomics.org

BiO network is on-line information source for all the areas of biological research, technology, training, and business. Anyone is welcome to contribute to and use the content with maximum freedom. Please visit our sites that are listed in. Some of our sites are. The free encyclopedia of biology. The internet sites directory for biological science, technology, and business. The free Oenomics portal. The Omics home page for everyone. The international portal for biological information for the countries.

pulmoguardhomecare.net

Index of /

Apache Server at www.pulmoguardhomecare.net Port 80.

pulmoigualada.cat

Rec: el Pulmó d'Igualada | HISTÒRIES IGUALADINES

Rec: el Pulmó d'Igualada. Museu de la Pell. Presentem el Rec, una part vital d'Igualada. L'antic motor d'Igualada. El nom de les fàbriques i adoberies del Rec. Vam decidir aquest tema, ja que és un tema que ens interessava perquè en un passat aquest barri va ser el motor d’Igualada, i el pa de moltes famílies. Si tens algun dubte, o simplement et vols posar en contacte amb nosaltres, pots contactar-hi via Instagram o Gmail! Vista superior del Rec. Museu de la Pell. Vida quotidina del Rec.